IHERO Electronic Patient Record

Interested Participants

If you're interested, please add your name and contact info.

Colin Field, Medical Physicist
- Cross Cancer Institute, Edmonton, AB, Canada
- email: cfield@cancerboard.ab.ca
- phone: 780-432-8625
Mahmoud M. EL-GANTIRY,Radiation Oncologist,
- National Cancer Institute – Cairo University, Kasr EL-Aini street, Kornish El-Nil, Fom El-Khalig, 11796, Cairo, Egypt.
- Cellular Tel: +2-0101799845.
- Fax: +202-23635083.
- e-mail: melgantiry@yahoo.com
Andrew Miller, Radiation Oncologist
- Illawarra Cancer Care Centre, Wollongong, NSW 2500 Australia.
- email: alexisandrew@gmail.com
- phone: +61409654239

Knowledge Representation of data elements has to match oncological thought
- calls for a diagnosis/time based approach to data where sequencing and reasoning is preserved

Demographics
- need a way to use demographics to produce a unique ID to produce anonymous records if transferred
Diagnosis
- utilizing a structure which is mapped (via UMLS)
  - presently
    - using ICD .... 9 (USA) 10 (AU, NZ, UK?)
    - predominantly for malignant diagnosis alone
    - already includes structured morphology nomenclature (e.g. SNOMED
  - FUTURE
    - include all benign diagnoses (these are likely to be be transferrable from other specialties and GPs)
    - expanded morphology descriptors that include immunohistochemical patterns, genetic changes
Stage
- utilizing a structure which is mapped (via UMLS)
  - presently we use AJCC/UICC
  - in the future
    - utilizing more specific anatomical definitions
      - derived from CT/MRI/PET anatomy (?DICOM-SR subset)
      - described in an Anatomical Ontology
Intent of Oncological Plan
Employed Modalities
Modality Details